Extra proxy material
Open the filing on sec.gov
HeartSciences Inc. (HSCS)
Nasdaq: HSCS · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Southlake, TX · filing with the SEC since 2009
The companyfiscal 2026, as filed
Revenue$4319.00-0.7%
Net income-$9.1M-4.3%
Earnings per share$-3.48+62.7%
Operating cash flow-$7.4M-0.2%
Cash$1.7M+54.8%
Debtn/a
Shareholders’ equity$226,060+10.2%
Shares, diluted2,625,421+179.8%
Return on equityn/a
The recordfrom its filings
Filings in 2026124
Newest filingNov 12 · DEFA14A
Annual reportJul 23, 2026
Quarterly reportSep 14, 2026
Next report due10-Q by Dec 15
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents granted9
Filer category<br>Emerging growth company
Trailing twelve months to Jul 2026Revenue $4519.00Net income -$10.3MCash from operations -$6.8Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
News
Extra proxy material
Open the filing on sec.gov
Extra proxy material
Open the filing on sec.gov
Extra proxy material
Open the filing on sec.gov
Extra proxy material
Open the filing on sec.gov
Extra proxy material
Open the filing on sec.gov
Extra proxy material
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Extra proxy material
Open the filing on sec.gov
Extra proxy material
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.